InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Egeland Ryan, Directeur Médical. Director active across 1 companies, notably Cardiovascular Systems Inc. Aggregated, 8 filings have been recorded. The latest transaction was filed on 8 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
05,477 shares0
Common Stock
SEC:0001437749-22-002882·
05,477 shares0
Common Stock
SEC:0001437749-22-002882:0·
01,107 shares0
Common Stock
SEC:0000914190-21-000292·
01,107 shares0
Common Stock
SEC:0000914190-21-000292:0·
€55,9361,820 shares@ €30.7338100.0% of flow
Common Stock
SEC:0000914190-21-000277·
€55,9361,820 shares@ €30.733850.0% of flow
Common Stock
SEC:0000914190-21-000277:0·
04,438 shares0
Common Stock
SEC:0000914190-21-000240·
04,438 shares0
Common Stock
SEC:0000914190-21-000240:0·
8 of 8 declarations
About Egeland Ryan
Ryan Egeland is the Chief Medical Officer at Cardiovascular Systems Inc. He is responsible for the medical direction and innovation in the development of medical devices for the treatment of cardiovascular diseases. Ryan brings valuable clinical expertise to guide the company's research and development initiatives.
